These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 20585194)

  • 21. Three-dimensional dynamic liver MR imaging using sensitivity encoding for detection of hepatocellular carcinomas: comparison with superparamagnetic iron oxide-enhanced mr imaging.
    Kim YK; Kim CS; Kwak HS; Lee JM
    J Magn Reson Imaging; 2004 Nov; 20(5):826-37. PubMed ID: 15503325
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The value of breath-hold diffusion-weighted imaging in small hepatocellular carcinoma lesion (Xu PJ; Yan FH; Wang JH; Lin J; Ji Y; Chen CZ; Shen JZ; Li RC
    Zhonghua Yi Xue Za Zhi; 2009 Mar; 89(9):592-6. PubMed ID: 19595157
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diffusion-weighted imaging of the liver: technical challenges and prospects for the future.
    Naganawa S; Kawai H; Fukatsu H; Sakurai Y; Aoki I; Miura S; Mimura T; Kanazawa H; Ishigaki T
    Magn Reson Med Sci; 2005 Dec; 4(4):175-86. PubMed ID: 16543702
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Detection and characterization of hepatocellular carcinoma in rats with liver cirrhosis: diagnostic value of combined use of MR positive and negative contrast agents.
    Guo DM; Qiu TS; Bian J; Liu SF; Wang CZ
    Hepatobiliary Pancreat Dis Int; 2009 Feb; 8(1):65-70. PubMed ID: 19208518
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatocellular carcinoma in patients with chronic liver disease: comparison of SPIO-enhanced MR imaging and 16-detector row CT.
    Kim YK; Kwak HS; Kim CS; Chung GH; Han YM; Lee JM
    Radiology; 2006 Feb; 238(2):531-41. PubMed ID: 16371577
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Hepatic and hepatocarcinoma magnetic resonance: comparison of the results obtained with paramagnetic (gadolinium) and superparamagnetic (iron oxide particles) contrast media].
    Castoldi MC; Fauda V; Scaramuzza D; Vergnaghi D
    Radiol Med; 2000 Sep; 100(3):160-7. PubMed ID: 11148882
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Added value of breathhold diffusion-weighted MRI in detection of small hepatocellular carcinoma lesions compared with dynamic contrast-enhanced MRI alone using receiver operating characteristic curve analysis.
    Xu PJ; Yan FH; Wang JH; Lin J; Ji Y
    J Magn Reson Imaging; 2009 Feb; 29(2):341-9. PubMed ID: 19161186
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Use of SPIO-enhanced T1- and T2-weighted images for the differentiation of liver lesions: an ROC analysis].
    Stroszczynski C; Gaffke G; Gretschel S; Rambow A; Jost D; Schlecht I; Schneider U; Schicke B; Hohenberger P; Gebauer B; Felix R
    Rofo; 2003 Oct; 175(10):1368-75. PubMed ID: 14556106
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Simultaneous detection of hepatocellular carcinoma and vessel thrombus by using SPIO-enhanced B-TFE with the T
    Kanamoto M; Miyati T; Terashima K; Katahira K; Ida R; Suga D; Fuwa N
    Radiol Phys Technol; 2017 Jun; 10(2):234-239. PubMed ID: 28160221
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Focal hepatic lesions: detection and characterization with combination gadolinium- and superparamagnetic iron oxide-enhanced MR imaging.
    Kim MJ; Kim JH; Chung JJ; Park MS; Lim JS; Oh YT
    Radiology; 2003 Sep; 228(3):719-26. PubMed ID: 12881583
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Detection of hepatocellular carcinoma in patients with cirrhosis: MR imaging versus angiographically assisted helical CT.
    Kanematsu M; Hoshi H; Murakami T; Inaba Y; Kim T; Yamada T; Kato M; Yokoyama R; Nakamura H
    AJR Am J Roentgenol; 1997 Dec; 169(6):1507-15. PubMed ID: 9393154
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combination of CT during arterial portography and double-phase CT hepatic arteriography with multi-detector row helical CT for evaluation of hypervascular hepatocellular carcinoma.
    Tsurusaki M; Sugimoto K; Fujii M; Fukuda T; Matsumoto S; Sugimura K
    Clin Radiol; 2007 Dec; 62(12):1189-97. PubMed ID: 17981167
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of hemodynamic imaging findings of hypervascular hepatocellular carcinoma: comparison between dynamic contrast-enhanced magnetic resonance imaging using radial volumetric imaging breath-hold examination with k-space-weighted image contrast reconstruction and dynamic computed tomography during hepatic arteriography.
    Kurozumi M; Fujinaga Y; Kitou Y; Yamada A; Ohya A; Adachi Y; Tsukahara Y; Nickel MD; Maruyama K; Uehara T; Miyagawa SI; Kadoya M
    Jpn J Radiol; 2018 Apr; 36(4):295-302. PubMed ID: 29327116
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intravoxel incoherent motion diffusion-weighted magnetic resonance imaging for predicting histological grade of hepatocellular carcinoma: Comparison with conventional diffusion-weighted imaging.
    Zhu SC; Liu YH; Wei Y; Li LL; Dou SW; Sun TY; Shi DP
    World J Gastroenterol; 2018 Feb; 24(8):929-940. PubMed ID: 29491686
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lesion discrimination with breath-hold hepatic diffusion-weighted imaging: a meta-analysis.
    Chen ZG; Xu L; Zhang SW; Huang Y; Pan RH
    World J Gastroenterol; 2015 Feb; 21(5):1621-7. PubMed ID: 25663782
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of gadoxetic acid-enhanced MRI and superparamagnetic iron oxide-enhanced MRI for the detection of hepatocellular carcinoma.
    Kim YK; Kim CS; Han YM; Park G; Hwang SB; Yu HC
    Clin Radiol; 2010 May; 65(5):358-65. PubMed ID: 20380933
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatocellular carcinoma in the cirrhotic liver: double-contrast MR imaging for diagnosis.
    Ward J; Guthrie JA; Scott DJ; Atchley J; Wilson D; Davies MH; Wyatt JI; Robinson PJ
    Radiology; 2000 Jul; 216(1):154-62. PubMed ID: 10887242
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Double phase CT during hepatic arteriography for diagnosis of hepatocellular carcinoma.
    Murakami T; Takamura M; Kim T; Hori M; Federle MP; Onishi H; Tomoda K; Nakamura H
    Eur J Radiol; 2005 May; 54(2):246-52. PubMed ID: 15837405
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diagnostic performance of gadoxetic acid (Primovist)-enhanced MR imaging versus CT during hepatic arteriography and portography for small hypervascular hepatocellular carcinoma.
    Yim SY; Park BJ; Um SH; Han NY; Sung DJ; Cho SB; Lee SH; Kim MJ; Jung JY; Kim JD; Seo YS; Kim DS; An H; Kim YH
    Medicine (Baltimore); 2016 Sep; 95(39):e4903. PubMed ID: 27684824
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hepatic lesion detection and characterization: value of nonenhanced MR imaging, superparamagnetic iron oxide-enhanced MR imaging, and spiral CT-ROC analysis.
    Reimer P; Jähnke N; Fiebich M; Schima W; Deckers F; Marx C; Holzknecht N; Saini S
    Radiology; 2000 Oct; 217(1):152-8. PubMed ID: 11012438
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.